The second approach was on the basis of HO-1 induction by the known inducer of this enzyme, hemin, which improved angiotensin-II-(high-dose) dependent endothelial dysfunction and prevented activation of NADPH oxidase in HO-1+/+ mice (Figures 2(c) and 2(d)). The gene discussed is AGT; the disease is endothelial dysfunction.